Abiopharma

New Form SCHEDULE 13G - Lyra Therapeutics, Inc. Filed: 2026-01-20 AccNo: 0001535610-26-000011 Size: 9 KB

Director Gano Kyle 🟡 adjusted position in 36.4K shares (2 derivative) of NEUROCRINE BIOSCIENCES INC (NBIX) at $132.71 ($7.5M) Transaction Date: Jan 16, 2026 | Filing ID: 000002

Elazzouzi Amy 🔴 sold 1.6K shares of Aura Biosciences, Inc. (AURA) at $4.86 Transaction Date: Jan 20, 2026 | Filing ID: 016939

de los Pinos Elisabet 🔴 sold 16.9K shares of Aura Biosciences, Inc. (AURA) at $4.86 Transaction Date: Jan 20, 2026 | Filing ID: 016938

Burns Thomas William 🟡 adjusted position in 275.0K shares (2 derivative) of GLAUKOS Corp (GKOS) at $115.00 ($40.7M) Transaction Date: Jan 08, 2026 | Filing ID: 000002

Esposito Pamela 🟡 adjusted position in 5.5K shares (2 derivative) of Kymera Therapeutics, Inc. (KYMR) at $68.52 Transaction Date: Jan 20, 2026 | Filing ID: 016934

Kelley Shannon T 🔴 sold 692 shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) at $501.40 Transaction Date: Jan 20, 2026 | Filing ID: 002742

Saba Capital Management, L.P. 🔴 sold 37.2K shares of Sharps Technology Inc. (STSS) at $2.37 Transaction Date: Jan 15, 2026 | Filing ID: 000036

New Form SCHEDULE 13D/A - EXICURE, INC. Filed: 2026-01-20 AccNo: 0002046701-26-000005 Size: 8 KB

Director Taub Rebecca 🔴 sold 2.2K shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) at $490.77 ($1.1M) Transaction Date: Jan 20, 2026 | Filing ID: 002735